Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
CA Regulators Complete Review of Wildfire Risk Model California’s Department of Insurance has completed a review of the state’s first wildfire catastrophe model, which property/casualty insurers...
Trump Administration’s ‘AI Action Plan’ Targets State AI Regulation The Trump administration released an “AI Action Plan,” aimed at speeding the development of artificial...
In the span of just 36 days this spring and summer, the number of states offering unemployment benefits to striking workers doubled—to four. New Jersey was the first to offer such benefits, beginning...
Developing Anti-‘Debanking’ Trend in Red States? A new front appears to have opened in the ongoing battle over environmental, social and governance (ESG) investing. In March Idaho Gov. Brad...
FL Requests Medicaid Waiver to Bolster Health Workforce Florida is seeking a federal waiver to use Medicaid funding to expand its health care workforce, a plan that could be adopted by other states....
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Federal officials have uncovered significant problems with the systems and procedures states have been employing to “unwind” Medicaid coverage protections put in place during the pandemic. A senior official at the Centers for Medicare and Medicaid Services said many states have been conducting automatic or “ex parte” renewals based on state databases to determine whether residents are still eligible for Medicaid coverage, sending out renewal forms and disenrolling anyone who doesn’t return them. (NEW YORK TIMES)
The Centers for Medicare and Medicaid Services announced the first 10 medications selected for price negotiations with Medicare in accordance with the Inflation Reduction Act, signed by President Biden in August 2022. CMS prioritized drugs that account for the most Medicare spending and came on the market years ago but face little competition. (NEW YORK TIMES)
A group of 11 governors, led by South Dakota Gov. Kristi Noem (R), sent a letter to congressional leaders urging them to take action to address shortages of prescription drugs. Noting that 80% of the active ingredients in prescription drugs come from other countries, mainly China and India, the governors called for policies to "increase diversity in the manufacturing of generic medications with regards to both raw materials and final manufacturing," require greater transparency from the FDA regarding shortages and relax the guidance for medication expiration dates to extend its shelf life. (CENTER SQUARE)
—Compiled by SNCJ Managing Editor KOREY CLARK
Please visit our webpage to connect with a State Net® representative and learn how the State Net legislative and regulatory tracking solution can help you identify, track, analyze and report on relevant legislative and regulatory developments.